Table I.
Clinical characteristics of the study subjects.
| Groups | ||||
|---|---|---|---|---|
|
|
||||
| Characteristics | CHB | ACLF | Cirrhosis | HC |
| Patients, n | 35 | 34 | 40 | 19 |
| Age, years | 38.53±15.63 | 37.44±12.40 | 49.88±12.90 | 21.93±0.83 |
| Gender, male/female, n | 29/6 | 26/8 | 31/9 | 7/12 |
| ALT, IU/l (normal scale, 0–40) | 106.47±127.50 | 104.27±114.37 | 56.48±53.29 | NA |
| TBIL, μM (normal scale, 0–17.1) | 46.08±35.12 | 306.38±206.50 | 73.44±71.25 | NA |
| WBC, ×109 | 4.89±2.06 | 4.24±1.57 | 3.83±2.21 | NA |
| Lymphocyte count, ×109 | 1.55±0.65 | 1.29±0.48 | 1.29±0.90 | NA |
| Percentage of lymphocytes, % | 33.58±10.66 | 32.22±12.24 | 33.90±14.57 | NA |
| HBV DNA, log10 IU/ml | 5.56±1.38 | 3.79±2.38 | 3.79±2.75 | NA |
CHB, chronic hepatitis B; ACLF, acute-on-chronic liver failure; HC, healthy controls; NA, not available; ALT, alanine aminotransferase; TBIL, total bilirubin; WBC, white blood cell; HBV, hepatitis B virus.